Vericel Corporation

Symbol: VCEL

NASDAQ

47.69

USD

Market price today

  • -1124.9798

    P/E Ratio

  • -16.7936

    PEG Ratio

  • 2.31B

    MRK Cap

  • 0.00%

    DIV Yield

Vericel Corporation (VCEL) Stock Price & Analysis

Shares Outstanding

48.38M

Gross Profit Margin

0.69%

Operating Profit Margin

-0.03%

Net Profit Margin

-0.01%

Return on Assets

-0.01%

Return on Equity

-0.01%

Return on Capital Employed

-0.02%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Dominick C. Colangelo Esq.
Full-time employees:314
City:Cambridge
Address:64 Sidney Street
IPO:1997-02-04
CIK:0000887359

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

General Outlook

In simple terms, Vericel Corporation has 48.38 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.686% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.033%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.010%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.006% return, is a testament to Vericel Corporation's adeptness in optimizing resource deployment. Vericel Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.010%. Furthermore, the proficiency of Vericel Corporation in capital utilization is underscored by a remarkable -0.021% return on capital employed.

Stock Prices

Vericel Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $48.65, while its low point bottomed out at $45.46. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Vericel Corporation's stock market.

Liquidity Ratios

Analyzing VCEL liquidity ratios reveals its financial health of the firm. The current ratio of 449.48% gauges short-term asset coverage for liabilities. The quick ratio (405.89%) assesses immediate liquidity, while the cash ratio (189.88%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio449.48%
Quick Ratio405.89%
Cash Ratio189.88%

Profitability Ratios

VCEL profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -1.20% underscores its earnings before tax deductions. The effective tax rate stands at 54.48%, revealing its tax efficiency. The net income per EBT, 85.47%, and the EBT per EBIT, 36.63%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -3.27%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-1.20%
Effective Tax Rate54.48%
Net Income per EBT85.47%
EBT per EBIT36.63%
EBIT per Revenue-3.27%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.49, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 338.47% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding406
Days of Inventory Outstanding77
Operating Cycle184.96
Days of Payables Outstanding132
Cash Conversion Cycle53
Receivables Turnover3.38
Payables Turnover2.77
Inventory Turnover4.73
Fixed Asset Turnover1.72
Asset Turnover0.56

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.74, and free cash flow per share, 0.16, depict cash generation on a per-share basis. The cash per share value, 2.67, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.18, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.74
Free Cash Flow per Share0.16
Cash per Share2.67
Operating Cash Flow Sales Ratio0.18
Free Cash Flow to Operating Cash Flow Ratio0.22
Cash Flow Coverage Ratio0.40
Short Term Coverage Ratio5.71
Capital Expenditure Coverage Ratio1.28
Dividend Paid and Capex Coverage Ratio1.28

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 24.90%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.39, we discern the balance between debt and equity financing. The long-term debt to capitalization, 26.59%, and total debt to capitalization, 28.04%, ratios shed light on its capital structure. An interest coverage of -10.77 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio24.90%
Debt Equity Ratio0.39
Long Term Debt to Capitalization26.59%
Total Debt to Capitalization28.04%
Interest Coverage-10.77
Cash Flow to Debt Ratio0.40
Company Equity Multiplier1.57

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.15, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.07, reflects the portion of profit attributed to each share. The book value per share, 4.75, represents the net asset value distributed per share, while the tangible book value per share, 4.60, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share4.15
Net Income Per Share-0.07
Book Value Per Share4.75
Tangible Book Value Per Share4.60
Shareholders Equity Per Share4.75
Interest Debt Per Share1.86
Capex Per Share-0.58

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 20.17%, indicates top-line expansion, while the gross profit growth, 23.49%, reveals profitability trends. EBIT growth, 62.11%, and operating income growth, 62.11%, offer insights into operational profitability progression. The net income growth, 80.96%, showcases bottom-line expansion, and the EPS growth, 80.89%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth20.17%
Gross Profit Growth23.49%
EBIT Growth62.11%
Operating Income Growth62.11%
Net Income Growth80.96%
EPS Growth80.89%
EPS Diluted Growth80.89%
Weighted Average Shares Growth0.98%
Weighted Average Shares Diluted Growth0.98%
Operating Cash Flow Growth99.64%
Free Cash Flow Growth-22.72%
10-Year Revenue Growth per Share65781.63%
5-Year Revenue Growth per Share83.83%
3-Year Revenue Growth per Share51.14%
10-Year Operating CF Growth per Share111.22%
5-Year Operating CF Growth per Share7347.31%
3-Year Operating CF Growth per Share90.95%
10-Year Net Income Growth per Share98.71%
5-Year Net Income Growth per Share66.93%
3-Year Net Income Growth per Share-205.57%
10-Year Shareholders Equity Growth per Share267.74%
5-Year Shareholders Equity Growth per Share86.89%
3-Year Shareholders Equity Growth per Share59.92%
Receivables Growth25.39%
Inventory Growth-18.13%
Asset Growth29.54%
Book Value per Share Growth16.38%
Debt Growth85.29%
R&D Expense Growth5.51%
SGA Expenses Growth13.18%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,695,956,900, captures the company's total value, considering both debt and equity. Income quality, -11.10, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 1.94%, indicates the value of non-physical assets, and capex to operating cash flow, -77.92%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value1,695,956,900
Income Quality-11.10
Research and Development to Revenue10.65%
Intangibles to Total Assets1.94%
Capex to Operating Cash Flow-77.92%
Capex to Revenue-13.93%
Capex to Depreciation-593.98%
Stock-Based Compensation to Revenue16.37%
Graham Number2.67
Return on Tangible Assets-0.92%
Graham Net Net1.05
Working Capital159,882,000
Tangible Asset Value219,077,000
Net Current Asset Value77,926,000
Average Receivables52,447,500
Average Payables19,638,500
Average Inventory14,536,500
Days Sales Outstanding108
Days Payables Outstanding132
Days of Inventory On Hand77
ROIC-2.77%
ROE-0.01%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 10.08, and the price to book ratio, 10.08, reflect the market's valuation relative to the company's book value. The price to sales ratio, 11.68, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 295.88, and price to operating cash flows, 64.48, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio10.08
Price to Book Ratio10.08
Price to Sales Ratio11.68
Price Cash Flow Ratio64.48
Price Earnings to Growth Ratio-16.79
Enterprise Value Multiple-2345.87
Price Fair Value10.08
Price to Operating Cash Flow Ratio64.48
Price to Free Cash Flows Ratio295.88
Price to Tangible Book Ratio7.50
Enterprise Value to Sales8.59
Enterprise Value Over EBITDA-925.74
EV to Operating Cash Flow48.03
Earnings Yield-0.19%
Free Cash Flow Yield0.46%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Vericel Corporation (VCEL) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -1124.980 in 2024.

What is the ticker symbol of Vericel Corporation stock?

The ticker symbol of Vericel Corporation stock is VCEL.

What is company IPO date?

IPO date of Vericel Corporation is 1997-02-04.

What is company current share price?

Current share price is 47.690 USD.

What is stock market cap today?

The market cap of stock today is 2307266045.000.

What is PEG ratio in 2024?

The current -16.794 is -16.794 in 2024.

What is the number of employees in 2024?

In 2024 the company has 314.